675 Safety and tolerability of magrolimab combination therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma (RM-HNSCC)A. Dimitrios Colevas, Douglas Adkins, Katie Kerrigan et al.|Regular and Young Investigator Award Abstracts|2023Cited by 1
Safety and Tolerability of Magrolimab Combination Therapy in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (RM-HNSCC)A. Dimitrios Colevas, Douglas Adkins, Y. Zhang et al.|International Journal of Radiation Oncology*Biology*Physics|2024Cited by 1
Real world characteristics and outcomes of patients with BRAFV600E-mutant metastatic colorectal cancer in Australia: The COALA project.Nadia Hitchen, Jeanne Tie, Hui‐Li Wong et al.|Journal of Clinical Oncology|2025Cited by 1
Real-world characteristics and outcomes of patients with BRAFV600E-mutant metastatic colorectal cancer in Australia: the COALA projectNadia Hitchen, J. Tie, Hui‐Li Wong et al.|ESMO Real World Data and Digital Oncology|2025Cited by 1
Real-world treatment patterns and clinical outcomes for patients with deficient mismatch repair (dMMR) metastatic colorectal cancer (mCRC).Vanessa Wong, Peter Gibbs, Grace Kim et al.|Journal of Clinical Oncology|2026Cited by 0